No abstract available
Keywords:
Abcès hépatique; Immune reconstitution inflammatory syndrome; Liver abscess; Syndrome inflammatoire de reconstitution immunitaire; Tuberculose; Tuberculosis.
MeSH terms
-
Adalimumab / adverse effects*
-
Adalimumab / therapeutic use
-
Adult
-
Antirheumatic Agents / adverse effects*
-
Antirheumatic Agents / therapeutic use
-
Antitubercular Agents / therapeutic use
-
Drug Substitution
-
Drug Therapy, Combination
-
Female
-
Humans
-
Immune Reconstitution Inflammatory Syndrome / chemically induced*
-
Immune Reconstitution Inflammatory Syndrome / complications
-
Immunocompromised Host
-
Latent Tuberculosis / complications
-
Liver Abscess / diagnostic imaging
-
Liver Abscess / drug therapy
-
Liver Abscess / etiology*
-
Mesalamine / therapeutic use
-
Proctocolitis / complications
-
Proctocolitis / drug therapy
-
Tuberculosis, Hepatic / drug therapy
-
Tuberculosis, Hepatic / etiology*
-
Tuberculosis, Lymph Node / complications
-
Tuberculosis, Lymph Node / drug therapy
-
Tuberculosis, Miliary / diagnosis
-
Tuberculosis, Miliary / drug therapy
-
Tuberculosis, Miliary / etiology*
-
Tuberculosis, Splenic / diagnostic imaging
-
Tuberculosis, Splenic / drug therapy
-
Tuberculosis, Splenic / etiology
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antirheumatic Agents
-
Antitubercular Agents
-
Tumor Necrosis Factor-alpha
-
Mesalamine
-
Adalimumab